ACACIA PHARMA
Acacia Pharma Ltd., a pharmaceutical company, discovers and develops supportive care drugs. The company focuses on cancer supportive care. Its products include APD405, an injectable formulation of an oral drug for the use of nausea and vomiting; APD209, which is for the use of cancer cachexia; and APD421, an intravenous formulation for the use of prevention and treatment of nausea and vomiting. The company also concentrates its discovery efforts in cancer related fatigue, cancer cachexia, and xerostomia. Acacia Pharma Ltd. was incorporated in 2006 and is based in Cambridge, United Kingdom.
ACACIA PHARMA
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2006-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.acaciapharma.com
Total Employee:
11+
Status:
Active
Contact:
+441223875130
Total Funding:
63.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Apache Wordpress Plugins
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Advisors List
Board_member
Current Employees Featured
Robert Gristwood CSO @ Acacia Pharma
CSO
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Debt Financing - Acacia Pharma
Novo Holdings
Novo Holdings investment in Series B - Acacia Pharma
Eight Roads Ventures
Eight Roads Ventures investment in Series B - Acacia Pharma
F-Prime Capital
F-Prime Capital investment in Series B - Acacia Pharma
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series B - Acacia Pharma
Gilde Healthcare
Gilde Healthcare investment in Series B - Acacia Pharma
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series A - Acacia Pharma
Gilde Healthcare
Gilde Healthcare investment in Series A - Acacia Pharma
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-06-04 | Cosmo Pharmaceuticals | Acacia Pharma investment in Post-IPO Debt - Cosmo Pharmaceuticals | 25 M USD |
Official Site Inspections
http://www.acaciapharma.com Semrush global rank: 4.86 M Semrush visits lastest month: 1.83 K
- Host name: ec2-52-1-123-40.compute-1.amazonaws.com
- IP address: 52.1.123.40
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
Acaciapharma.com lookup results from whois.ascio.com server:
- Domain created: 3rd-Jan-2007
- Domain updated: 5th-Nov-2024
- Domain expires: 3rd-Jan-2026 0 Years, 282 Days left
- Website age: 18 Years, 82 Days
- Registrar Domain ID: 737903700_DOMAIN_COM-VRSN
- Registrar Url: http://www.ascio.com
- Registrar WHOIS Server: whois.ascio.com
- Registrar Abuse Contact Email: abuse@ascio.com
- Registrar Abuse Contact Phone: +1.4165350123
- Name server:
- NS1.BDM.MICROSOFTONLINE.COM
- NS2.BDM.MICROSOFTONLINE.COM
- NS3.BDM.MICROSOFTONLINE.COM
- NS4.BDM.MICROSOFTONLINE.COM
More informations about "Acacia Pharma"
Contact - Acacia Pharma Group Plc
Regional Office - Acacia Pharma Inc 8440 Allison Pointe Boulevard, Suite 100, Indianapolis, IN 46250. USA. +1 (201) 326-5300. Investor Relations for Eagle Pharmaceuticals, Inc. Lisa M. …See details»
Acacia Pharma Information - RocketReach
Acacia Pharma, Inc. is a commercially driven hospital pharmaceutical group focused on the development and commercialization of new nausea and vomiting treatments for surgical and …See details»
Acacia Pharma Group plc Annual Report and Financial Statements …
Acacia Pharma Group plc Annual Report and Financial Statements for the year ended 31 December 2020 Registered number 09759376. Directors and advisers 1 Acacia Pharma at a …See details»
Acacia Pharma Group Company Profile | Management and
Acacia Pharma Group plc discovers, develops, and commercializes pharmaceutical products for the patients undergoing surgery, invasive procedures, or chemotherapy treatments in the …See details»
Acacia Pharma Company Profile: Overview and Full News Analysis
Acacia Pharma has developed a range of hospital products tailored for use by anesthesia and surgical teams, along with a promising late-stage development candidate targeting …See details»
Acacia Pharma - Crunchbase Company Profile
Acacia Pharma Ltd., a pharmaceutical company, discovers and develops supportive care drugs. The company focuses on cancer supportive care. Its products include APD405, an injectable formulation of an oral drug for the …See details»
Acacia Pharma Group - Overview, News & Similar companies
Who is Acacia Pharma Group. Acacia Pharma Group plc discovers, develops, and commercializes pharmaceutical products for the patients undergoing surgery, invasive …See details»
Acacia Pharma - VentureRadar
Acacia Pharma Raises £15M in Series B Financing. Source: finsmes.com. The Business Weekly - Ones2Watch (2012) Award. 10 Apr 2012. Company was one of 50 on the list. Source: The …See details»
Acacia Pharma - Craft
Jun 8, 2022 Acacia Pharma is a hospital pharmaceutical company. It focuses on the development and commercialization of products aimed at improving the care of patients …See details»
ACACIA PHARMA GROUP PLC Initial Public offering on Euronext
May 11, 2022 ACACIA PHARMA Symbol. ACPH ISIN code. GB00BYWF9Y76 ... Stocks Market organization. EuronextBrussels Capitalization compartment. Compartment B ICB. …See details»
Acacia Pharma Group Limited - Directors, Top Employee's
Acacia Pharma Group Limited - Top Contacts of Directors, Heads, CEO & Top Employees. Below Table Displays all the recently available contact numbers of top decision makers of Acacia …See details»
Publication of Annual Report and Financial Statements for the Year ...
Dec 31, 2021 Acacia Pharma Group plc Mike Bolinder, CEO +44 1223 919760 / +1 317 505 1280 IR@acaciapharma.com International Media Frazer Hall, Mark Swallow, David Dible …See details»
Acacia Pharma - LinkedIn
Acacia Pharma, Inc. is a commercially driven hospital pharmaceutical group focused on the development and commercialization of new nausea and vomiting treatments for surgical and …See details»
Acacia Pharma Group plc | Insights
Sep 30, 2022 Acacia Pharma Group Ltd. See more in Biomedtracker. Latest on Acacia Pharma Group plc. Already A Biomedtracker Subscriber? You have access to the full company record …See details»
Acacia Pharma Group plc - Results of Placing - EUR 27 million …
Feb 19, 2021 Acacia Pharma Limited (Registered in England and Wales No: 05934843) and Acacia Pharma Inc (Incorporated under the laws of Delaware, No: 5799660) are members of …See details»
Alpha Cognition Expands Commercial and Medical Teams with Key ...
22 hours ago Prior to that, Kurt served as Head of US Medical Affairs at Acacia Pharma, Inc., and built and led the Medical Affairs organization through the successful launch of two new …See details»
News - Acacia Pharma Group Plc
Aug 14, 2020 Acacia Pharma to Postpone Publication of its Results for the Full Year 2021, Scheduled on 31 March 2022. 29 March 2022. Scheme of Arrangement Information Sheet. 28 …See details»
Alpha Cognition Expands Commercial and Medical Teams with Key ...
2 days ago Prior to that, Kurt served as Head of US Medical Affairs at Acacia Pharma, Inc., and built and led the Medical Affairs organization through the successful launch of two new …See details»
Proposed Transaction with Eagle Pharmaceuticals, Inc (Part 2 of 2 ...
Mar 28, 2022 The board of directors of Acacia Pharma Group PLC (“Acacia”) and the board of directors of Eagle Pharmaceuticals, Inc. (“Eagle”) are pleased to announce that they have …See details»
News | Press Releases - Acacia Pharma Group Plc
Dec 31, 2021 Acacia Pharma to Postpone Publication of its Results for the Full Year 2021, Scheduled on 31 March 2022. 29 March 2022. Scheme of Arrangement Information Sheet. 28 …See details»